Qiagen N.V. (QGEN): Price and Financial Metrics

QGEN POWR Grades

• QGEN scores best on the Quality dimension, with a Quality rank ahead of 91.15% of US stocks.
• QGEN's strongest trending metric is Momentum; it's been moving down over the last 177 days.
• QGEN's current lowest rank is in the Momentum metric (where it is better than 1.11% of US stocks).

QGEN Stock Summary

• QIAGEN NV's market capitalization of $11,246,103,000 is ahead of 84.36% of US-listed equities.
• Revenue growth over the past 12 months for QIAGEN NV comes in at -0.65%, a number that bests just 23.19% of the US stocks we're tracking.
• The volatility of QIAGEN NV's share price is greater than that of just 8.14% US stocks with at least 200 days of trading history.
• If you're looking for stocks that are quantitatively similar to QIAGEN NV, a group of peers worth examining would be HOLX, LOGI, LFUS, CTS, and PKI.
• Visit QGEN's SEC page to see the company's official filings. To visit the company's web site, go to www.qiagen.com.

QGEN Valuation Summary

• In comparison to the median Healthcare stock, QGEN's price/earnings ratio is 3.17% higher, now standing at 22.8.
• Over the past 243 months, QGEN's price/sales ratio has gone up 2.

Below are key valuation metrics over time for QGEN.

QGEN Growth Metrics

The 4 year net cashflow from operations growth rate now stands at -14.46%.
• Its 2 year cash and equivalents growth rate is now at 16.43%.
• Its 2 year revenue growth rate is now at 49.23%.

Over the past 30 months, QGEN's revenue has gone up $676,065,000.

The table below shows QGEN's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	2,225.932	826.394	488.008
2022-06-30	2,261.046	733.338	514.298
2022-06-30	2,261.046	733.338	514.298
2022-03-31	2,312.842	717.784	538.688
2022-03-31	2,312.842	717.374	538.688
2021-12-31	2,251.657	639.001	512.599

QGEN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• QGEN has a Quality Grade of B, ranking ahead of 79.35% of graded US stocks.
• QGEN's asset turnover comes in at 0.375 -- ranking 125th of 682 Pharmaceutical Products stocks.
• ALNY, TXMD, and CASI are the stocks whose asset turnover ratios are most correlated with QGEN.

The table below shows QGEN's key quality metrics over time.